What is Joiya?
Joiya operates at the intersection of consumer wellness and natural health, specializing in premium products enriched with cannabinoids. The company addresses critical consumer needs, including stress, anxiety, pain management, and sleep optimization. Its diverse product portfolio—ranging from capsules and tinctures to micro mist sprays and topicals—is specifically engineered for individuals seeking holistic health solutions. By prioritizing quality assurance and offering a subscription-based model, Joiya has cultivated a loyal customer base, positioning itself as a reliable provider of wellness products for women and their families. The company's emphasis on efficacy and transparency serves as a key differentiator in the rapidly evolving cannabinoid market.
How much funding has Joiya raised?
Joiya has raised a total of $299K across 2 funding rounds:
Debt
$150K
Debt
$149K
Debt (2020): $150K with participation from PPP
Debt (2021): $149K led by PPP
Key Investors in Joiya
PPP
Public-Private Partnership
What's next for Joiya?
With this latest round of financing, Joiya is poised to enter a new phase of market penetration and product development. The strategic deployment of these funds will likely focus on enhancing supply chain efficiencies and expanding the reach of its subscription program. As the wellness industry continues to mature, Joiya's ability to maintain product integrity while scaling its distribution channels will be paramount. The company is expected to leverage this capital to refine its research and development efforts, potentially introducing new formulations that address emerging consumer health trends. By focusing on sustainable growth and customer retention, Joiya is strategically aligned to capture a larger share of the natural health market, ensuring long-term viability in an increasingly crowded landscape.
See full Joiya company page